REPORT ID 3909

Global Antibacterial Drug Resistance Market Professional Survey Report 2017

Publish Date
14-Dec-17
Pages
126
Format
Electronic (PDF)

This report studies Antibacterial Drug Resistance in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AAIPharma Services
    ANTABIO
    Abgentis
    Abbott Laboratories
    Absynth Biologics
    Achaogen
    Acino Holdings
    Aventis Pharma
    Austell Laboratories
    Assembly Biosciences
    Arpida
    Demuris
    Evolva Holding
    ContraFect
    Cerexa
    GSK
    InterMune
    Isis Pharmaceuticals
    Lyndra
    Microbecide
    Morphochem
    Nabriva Therapeutics
    NanoSafe Coatings
    Novexel
    Osel
    PENDOPHARM
    Pfizer
    VenatoRx Pharmaceuticals

By types, the market can be split into
    Telavancin (Vibativ)
    Ceftaroline Fosamil (Teflaro/ Zinforo)
    Fidaxomicin (Dificid / Dificlir)
    Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
    Dalbavancin (Dalvance/ Xydalba)
    Tedizolid Phosphate (Sivextro)
    Oritavancin (Orbactiv/ Nuvocid)
    Ceftolozane-Tazobactam (Zerbaxa)
    Ceftazidime-Avibactam (Avycaz/ Zavicefta)
    PHASE III DRUGS

By Application, the market can be split into
    Gram-Positive
    Gram-Negative

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Antibacterial Drug Resistance Market Professional Survey Report 2017
1 Industry Overview of Antibacterial Drug Resistance
    1.1 Definition and Specifications of Antibacterial Drug Resistance
        1.1.1 Definition of Antibacterial Drug Resistance
        1.1.2 Specifications of Antibacterial Drug Resistance
    1.2 Classification of Antibacterial Drug Resistance
        1.2.1 Telavancin (Vibativ)
        1.2.2 Ceftaroline Fosamil (Teflaro/ Zinforo)
        1.2.3 Fidaxomicin (Dificid / Dificlir)
        1.2.4 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
        1.2.5 Dalbavancin (Dalvance/ Xydalba)
        1.2.6 Tedizolid Phosphate (Sivextro)
        1.2.7 Oritavancin (Orbactiv/ Nuvocid)
        1.2.8 Ceftolozane-Tazobactam (Zerbaxa)
        1.2.9 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
        1.2.10 PHASE III DRUGS
    1.3 Applications of Antibacterial Drug Resistance
        1.3.1 Gram-Positive
        1.3.2 Gram-Negative
        1.3.3 Application 3
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Antibacterial Drug Resistance
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Antibacterial Drug Resistance
    2.3 Manufacturing Process Analysis of Antibacterial Drug Resistance
    2.4 Industry Chain Structure of Antibacterial Drug Resistance

3 Technical Data and Manufacturing Plants Analysis of Antibacterial Drug Resistance
    3.1 Capacity and Commercial Production Date of Global Antibacterial Drug Resistance Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Antibacterial Drug Resistance Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Antibacterial Drug Resistance Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Antibacterial Drug Resistance Major Manufacturers in 2016

4 Global Antibacterial Drug Resistance Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Antibacterial Drug Resistance Capacity and Growth Rate Analysis
        4.2.2 2016 Antibacterial Drug Resistance Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Antibacterial Drug Resistance Sales and Growth Rate Analysis
        4.3.2 2016 Antibacterial Drug Resistance Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Antibacterial Drug Resistance Sales Price
        4.4.2 2016 Antibacterial Drug Resistance Sales Price Analysis (Company Segment)

5 Antibacterial Drug Resistance Regional Market Analysis
    5.1 North America Antibacterial Drug Resistance Market Analysis
        5.1.1 North America Antibacterial Drug Resistance Market Overview
        5.1.2 North America 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.1.4 North America 2016 Antibacterial Drug Resistance Market Share Analysis
    5.2 China Antibacterial Drug Resistance Market Analysis
        5.2.1 China Antibacterial Drug Resistance Market Overview
        5.2.2 China 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.2.4 China 2016 Antibacterial Drug Resistance Market Share Analysis
    5.3 Europe Antibacterial Drug Resistance Market Analysis
        5.3.1 Europe Antibacterial Drug Resistance Market Overview
        5.3.2 Europe 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.3.4 Europe 2016 Antibacterial Drug Resistance Market Share Analysis
    5.4 Southeast Asia Antibacterial Drug Resistance Market Analysis
        5.4.1 Southeast Asia Antibacterial Drug Resistance Market Overview
        5.4.2 Southeast Asia 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.4.4 Southeast Asia 2016 Antibacterial Drug Resistance Market Share Analysis
    5.5 Japan Antibacterial Drug Resistance Market Analysis
        5.5.1 Japan Antibacterial Drug Resistance Market Overview
        5.5.2 Japan 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.5.4 Japan 2016 Antibacterial Drug Resistance Market Share Analysis
    5.6 India Antibacterial Drug Resistance Market Analysis
        5.6.1 India Antibacterial Drug Resistance Market Overview
        5.6.2 India 2012-2017E Antibacterial Drug Resistance Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Antibacterial Drug Resistance Sales Price Analysis
        5.6.4 India 2016 Antibacterial Drug Resistance Market Share Analysis

6 Global 2012-2017E Antibacterial Drug Resistance Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Antibacterial Drug Resistance Sales by Type
    6.2 Different Types of Antibacterial Drug Resistance Product Interview Price Analysis
    6.3 Different Types of Antibacterial Drug Resistance Product Driving Factors Analysis
        6.3.1 Telavancin (Vibativ) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.2 Ceftaroline Fosamil (Teflaro/ Zinforo) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.3 Fidaxomicin (Dificid / Dificlir) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.4 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.5 Dalbavancin (Dalvance/ Xydalba) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.6 Tedizolid Phosphate (Sivextro) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.7 Oritavancin (Orbactiv/ Nuvocid) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.8 Ceftolozane-Tazobactam (Zerbaxa) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.9 Ceftazidime-Avibactam (Avycaz/ Zavicefta) of Antibacterial Drug Resistance Growth Driving Factor Analysis
        6.3.10 PHASE III DRUGS of Antibacterial Drug Resistance Growth Driving Factor Analysis

7 Global 2012-2017E Antibacterial Drug Resistance Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Antibacterial Drug Resistance Consumption by Application
    7.2 Different Application of Antibacterial Drug Resistance Product Interview Price Analysis
    7.3 Different Application of Antibacterial Drug Resistance Product Driving Factors Analysis
        7.3.1 Gram-Positive of Antibacterial Drug Resistance Growth Driving Factor Analysis
        7.3.2 Gram-Negative of Antibacterial Drug Resistance Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antibacterial Drug Resistance
    8.1 AAIPharma Services
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AAIPharma Services 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AAIPharma Services 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.2 ANTABIO
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 ANTABIO 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 ANTABIO 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.3 Abgentis
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Abgentis 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Abgentis 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.4 Abbott Laboratories
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Abbott Laboratories 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Abbott Laboratories 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.5 Absynth Biologics
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Absynth Biologics 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Absynth Biologics 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.6 Achaogen
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Achaogen 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Achaogen 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.7 Acino Holdings
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Acino Holdings 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Acino Holdings 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.8 Aventis Pharma
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Aventis Pharma 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Aventis Pharma 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.9 Austell Laboratories
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Austell Laboratories 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Austell Laboratories 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.10 Assembly Biosciences
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Assembly Biosciences 2016 Antibacterial Drug Resistance Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Assembly Biosciences 2016 Antibacterial Drug Resistance Business Region Distribution Analysis
    8.11 Arpida
    8.12 Demuris
    8.13 Evolva Holding
    8.14 ContraFect
    8.15 Cerexa
    8.16 GSK
    8.17 InterMune
    8.18 Isis Pharmaceuticals
    8.19 Lyndra
    8.20 Microbecide
    8.21 Morphochem
    8.22 Nabriva Therapeutics
    8.23 NanoSafe Coatings
    8.24 Novexel
    8.25 Osel
    8.26 PENDOPHARM
    8.27 Pfizer
    8.28 VenatoRx Pharmaceuticals

9 Development Trend of Analysis of Antibacterial Drug Resistance Market
    9.1 Global Antibacterial Drug Resistance Market Trend Analysis
        9.1.1 Global 2017-2022 Antibacterial Drug Resistance Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Antibacterial Drug Resistance Sales Price Forecast
    9.2 Antibacterial Drug Resistance Regional Market Trend
        9.2.1 North America 2017-2022 Antibacterial Drug Resistance Consumption Forecast
        9.2.2 China 2017-2022 Antibacterial Drug Resistance Consumption Forecast
        9.2.3 Europe 2017-2022 Antibacterial Drug Resistance Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Antibacterial Drug Resistance Consumption Forecast
        9.2.5 Japan 2017-2022 Antibacterial Drug Resistance Consumption Forecast
        9.2.6 India 2017-2022 Antibacterial Drug Resistance Consumption Forecast
    9.3 Antibacterial Drug Resistance Market Trend (Product Type)
    9.4 Antibacterial Drug Resistance Market Trend (Application)

10 Antibacterial Drug Resistance Marketing Type Analysis
    10.1 Antibacterial Drug Resistance Regional Marketing Type Analysis
    10.2 Antibacterial Drug Resistance International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Antibacterial Drug Resistance by Region
    10.4 Antibacterial Drug Resistance Supply Chain Analysis

11 Consumers Analysis of Antibacterial Drug Resistance
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    ?

12 Conclusion of the Global Antibacterial Drug Resistance Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source